TORONTO, April 25,
2022 /CNW/ - HLS Therapeutics Inc. ("HLS" or the
"Company") (TSX: HLS), a pharmaceutical company focused on central
nervous system and cardiovascular markets, announces that
Gilbert Godin, Chief Executive
Officer, will present at the Bloom Burton & Co. Healthcare
Investor Conference, which takes place Monday May 2 - Tuesday May 3, 2022 at the Metro
Toronto Convention Centre in downtown Toronto.
HLS will present on May 2, 2022,
at 10:00 a.m. Eastern Time. The
Company's presentation will be webcast at:
https://wsw.com/webcast/bloomburton7/hls.to/3106608. Mr. Godin and
Tim Hendrickson, Chief Financial
Officer, will also host one-on-one meetings with investors at the
conference. To request a one-on-one meeting, please contact your
Bloom Burton representative.
ABOUT HLS THERAPEUTICS INC.
Formed in 2015, HLS is a pharmaceutical company focused on the
acquisition and commercialization of late-stage development,
commercial stage promoted and established branded pharmaceutical
products in the North American markets. HLS's focus is on products
targeting the central nervous system and cardiovascular therapeutic
areas. HLS's management team is composed of seasoned pharmaceutical
executives with a strong track record of success in these
therapeutic areas and at managing products in each of these
lifecycle stages. For more information, please visit:
www.hlstherapeutics.com
ABOUT THE CONFERENCE
The Bloom Burton & Co. Healthcare Investor Conference brings
together U.S., Canadian and international investors who are
interested in the latest developments in the Canadian healthcare
sector. Attendees will have an opportunity to obtain corporate
updates from the premier Canadian publicly traded and private
companies through presentations and private meetings.
ABOUT BLOOM BURTON &
CO.
Bloom Burton & Co. is a firm dedicated to accelerating
returns in the healthcare sector for both investors and companies.
Bloom Burton has an experienced team of medical, scientific,
pharmaceutical, legal and capital markets professionals who perform
a deep level of diligence, which combined with our creative and
entrepreneurial approach, assists our clients in achieving the
right monetization events. Bloom Burton and its affiliates provide
capital raising, M&A advisory, equity research, business
strategy and scientific consulting, advisory on direct investing
and company creation and incubation services. Bloom Burton
Securities Inc. is a member of the Investment Industry Regulatory
Organization of Canada (IIROC) and
is also a member of the Canadian Investor Protection Fund
(CIPF).
SOURCE HLS Therapeutics Inc.